By Stephen Nakrosis
WCG Clinical, Inc. on Wednesday filed with the Securities and Exchange Commission to withdraw its initial public offering.
The company said it no longer wishes to conduct the offering at this time.
In August, the company said it planned to offer 45 million shares and expected the offering to price between $15 and $17 per share.
WCG Clinical said it provides clinical trial solutions and added it is "focused on providing solutions that are designed to measurably improve the quality and efficiency of clinical research, stimulate growth and foster compliance."
The company said it had total revenue of $137.6 million for the three months ended March 31, 2021. In the three months ended March 31, 2020, the company said, it had total revenue of $103.4 million.
Write to Stephen Nakrosis at stephen.nakrosis@wsj.com
